Systems Oncology Announces Pipeline of Innovative Drugs Emerging from the Use of Artificial Intelligence
Systems Oncology Announces Pipeline of Innovative Drugs Emerging from the Use of Artificial Intelligence
Dec 14, 2018
_ Dr. Spyro Mousses, CEO of Systems Oncology, LLC, announced Systems Oncology’s diversified pipeline of innovative oncology programs discovered with the help of Artificial Intelligence at the AIMed North America Conference in Dana Point, California. As a result of this approach, Systems Oncology has discovered hundreds of breakthrough therapeutic opportunities which have been successfully translated into multiple pre-clinical development programs. Systems Oncology’s AI Platform has proven that AI can be used to accelerate the discovery and development of novel therapeutics.